The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients

NCT00142220 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2006-09-11

No results posted yet for this study

Summary

We study whether an increased proportion of omega-3-fatty acids (contained in fish oil) in the nutrition of critically ill patients reduces systemic inflammation.

Conditions

  • Sepsis Syndrome

Interventions

DRUG

Defined percentage of omega-3-fatty acids

Sponsors & Collaborators

  • Fresenius AG

    collaborator INDUSTRY
  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Sigrun Friesecke, Dr. · University Medicine Greifswald

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00142220 on ClinicalTrials.gov